Pages that link to "Q67981546"
Jump to navigation
Jump to search
The following pages link to Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management (Q67981546):
Displaying 42 items.
- Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma (Q26771059) (← links)
- The clinical characteristics and treatment results of ocular adnexal lymphoma (Q34014905) (← links)
- Positron emission tomography and gallium metabolic imaging in lymphoma (Q34214889) (← links)
- Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography (Q34495333) (← links)
- Positron Emission Tomography (PET) in Oncology (Q34774840) (← links)
- Assessment of response to therapy using conventional imaging (Q35094205) (← links)
- Post-treatment surveillance of patients with lymphoma treated with curative intent (Q35180571) (← links)
- A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma (Q35551019) (← links)
- Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas (Q36508858) (← links)
- Magnetic resonance imaging for the assessment of residual masses after treatment of non-Hodgkin's lymphomas (Q36683137) (← links)
- Imaging guiding therapy development in lymphoma. (Q37273290) (← links)
- Impact of FDG-PET/CT in the management of lymphoma (Q37950857) (← links)
- Role of PET in lymphoma (Q38195220) (← links)
- Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers (Q38838285) (← links)
- The evolving role of F-FDG PET scans in patients with aggressive non-Hodgkin's lymphoma (Q39491710) (← links)
- Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment (Q39950405) (← links)
- Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria). (Q39976687) (← links)
- Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates (Q41740650) (← links)
- Lymphoma: a clinical view (Q42926735) (← links)
- Mediastinal single nodal relapse of a nasal NK/T cell lymphoma (Q43121344) (← links)
- Lymphoblastic lymphoma and Burkitt’s lymphoma in Caucasian adults: Please don’t forget the pediatric experience (Q43710588) (← links)
- Predictive value of early 18F‐fluoro‐deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma (Q44609902) (← links)
- FDG-PET/CT in re-staging of patients with lymphoma (Q44675379) (← links)
- Consolidation radiotherapy for advanced-stage aggressive B-cell non-Hodgkin lymphoma: A systematic review and meta-analysis (Q47139559) (← links)
- Relationship Between Dual Time Point FDG PET/CT and Clinical Prognostic Indexes in Patients with High Grade Lymphoma: a Pilot Study (Q48535641) (← links)
- Pediatric lymphoma: metabolic tumor burden as a quantitative index for treatment response evaluation (Q50997691) (← links)
- Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival (Q53235861) (← links)
- Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments? (Q53250854) (← links)
- [18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner (Q60606978) (← links)
- Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses? (Q61868245) (← links)
- An alternating chemotherapy combination (macoble) for intermediate and high-grade non-hodgkin's lymphoma (Q67697068) (← links)
- Promace-C-Mopp in Aggressive Non-Hodgkin's Lymphoma Long-Term Results in 45 Patients Treated in a Single Institution (Q67810537) (← links)
- Residual mediastinal widening following therapy in Hodgkin's disease (Q68859989) (← links)
- Non-Hodgkin's lymphoma (Q71779941) (← links)
- Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas (Q72257296) (← links)
- Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography (Q72753390) (← links)
- How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin's lymphoma patients? (Q73245454) (← links)
- Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT (Q80413759) (← links)
- FDG-PET/CT in Lymphoma (Q83436647) (← links)
- Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma (Q92219793) (← links)
- INFRADIAPHRAGMAL RADIOTHERAPY IN PATIENTS WITH LYMPHOMA: VOLUME DEFINITION AND SIDE EFFECTS (Q92549244) (← links)
- Benign Histiocyte-Rich Pseudotumor Developing Postchemotherapy and Mimicking Residual Disease (Q97645583) (← links)